04Apr/14

Sirolimus Reduces Post-Transplant HIV Levels – Renal and Urology News

Immunosuppressive Drugs

Counsel & Heal

Sirolimus Reduces Post-Transplant HIV Levels
Renal and Urology News
Immunosuppressant therapy taken following kidney transplantation may help reduce persistent HIV burdens in infected patients, according to a study published in the American Journal of Transplantation. Peter G. Stock, M.D., Ph.D., from University of …
Can a transplant drug help eliminate lingering HIV infections?Los Angeles Times
Could transplant drugs replace antiretrovirals in HIV treatment?Medical News Today
Transplant Drugs May Help Wipe Out Persistent HIV InfectionsRedOrbit

all 16 news articles »
04Apr/14

Can a transplant drug help eliminate lingering HIV infections? – Los Angeles Times

Immunosuppressive Drugs

Counsel & Heal

Can a transplant drug help eliminate lingering HIV infections?
Los Angeles Times
In a paper published this week in the American Journal of Transplantation, authors found that when a small group of transplant patients received the drug sirolimus, they experienced a two- to threefold drop in HIV levels, whereas patients who received …
Sirolimus Reduces Post-Transplant HIV LevelsRenal and Urology News
Could transplant drugs replace antiretrovirals in HIV treatment?Medical News Today
Transplant Drugs May Help Wipe Out Persistent HIV InfectionsRedOrbit

all 17 news articles »
03Apr/14

Bayer Initiates Xofigo Combination Study – Analyst Blog – NASDAQ

Immunosuppressive Drugs

Bayer Initiates Xofigo Combination Study – Analyst Blog
NASDAQ
The study will evaluate the effects of Xofigo in combination with Johnson & Johnson ‘s ( JNJ ) Zytiga (abiraterone acetate) and prednisone/prednisolone on symptomatic skeletal event-free survival. We note that Xofigo is already approved in the EU for …
Bayer HealthCare begins new prostate cancer drug trialZenopa

all 3 news articles »